Industry News
Zeiss Medical Technology Receives NMPA Approval for ILM-Blue in China

Zeiss Medical Technology has announced that ILM-Blue, an internal limiting membrane (ILM) dye develo...

read more
Zeiss Medical Technology Receives NMPA Approval for ILM-Blue in China
April 02, 2025
OKYO Pharma Reports Positive Long-Term Stability Data for Urcosimod in Neuropathic Corneal Pain

OKYO Pharma has announced encouraging data on the long-term stability of urcosimod (formerly OK-101)...

read more
OKYO Pharma Reports Positive Long-Term Stability Data for Urcosimod in Neuropathic Corneal Pain
April 02, 2025
Sydnexis Receives Positive CHMP Opinion for SYD-101 to Treat Pediatric Myopia in Europe

Sydnexis has announced a significant milestone with the European Medicines Agency’s (EMA) Committee ...

read more
Sydnexis Receives Positive CHMP Opinion for SYD-101 to Treat Pediatric Myopia in Europe
April 02, 2025
Pantheon Vision Partners with EyeDeal Medical to Develop Bioengineered Corneal Implant

Pantheon Vision has announced a strategic partnership with EyeDeal Medical to co-develop a bioengine...

read more
Pantheon Vision Partners with EyeDeal Medical to Develop Bioengineered Corneal Implant
March 28, 2025
Alcon Acquires Majority Stake in Aurion Biotech to Advance Cell Therapy for Corneal Disease

Alcon has officially acquired a majority interest in Aurion Biotech, a clinical-stage biotech compan...

read more
Alcon Acquires Majority Stake in Aurion Biotech to Advance Cell Therapy for Corneal Disease
March 28, 2025
Bausch + Lomb Issues Voluntary Recall of Select enVista Intraocular Lenses

Bausch + Lomb has initiated a voluntary recall of specific intraocular lenses (IOLs) from its enVist...

read more
Bausch + Lomb Issues Voluntary Recall of Select enVista Intraocular Lenses
March 28, 2025
Alsanza Highlights Presbyopia correction with Fourier IOLs

Alsanza GmbH, a company known for its innovative ophthalmic products, continues to draw attention to...

read more
Alsanza Highlights Presbyopia correction with Fourier IOLs
March 27, 2025
Character Biosciences Secures $93 Million to Advance Genetics-Based Therapeutics for AMD

Character Biosciences has closed an oversubscribed $93 million Series B financing round, which will ...

read more
Character Biosciences Secures $93 Million to Advance Genetics-Based Therapeutics for AMD
March 27, 2025
Nanoscope Therapeutics Publishes Clinical Data Demonstrating Vision Restoration in Retinitis Pigmentosa

Nanoscope Therapeutics has announced the publication of clinical data on vision restoration in patie...

read more
Nanoscope Therapeutics Publishes Clinical Data Demonstrating Vision Restoration in Retinitis Pigmentosa
March 27, 2025
Surrozen Shifts Strategic Focus to Ophthalmology, Discontinues Liver Program

Surrozen has announced a strategic shift in its pipeline, transitioning its Wnt signaling expertise ...

read more
Surrozen Shifts Strategic Focus to Ophthalmology, Discontinues Liver Program
March 26, 2025
More